Holding(s) in Company

RNS Number : 8181V

Proteome Sciences PLC

16 July 2009

 



Proteome Sciences plc

('Proteome' or the 'Company')

Holding(s) in Company

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii		Proteome Sciences plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached			No
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments			No
An event changing the breakdown of voting rights			No
Other (please specify):			No
3. Full name of person(s) subject to the notification obligation: iii	Cubana Investments Limited
4. Full name of shareholder(s)   (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v	19th June 2009
6. Date on which issuer notified:	15th July 2009
7. Threshold(s) that is/are crossed or reached: vi, vii	>11%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003104196

13,287,183

13,287,183

15,187,465

15,187,465

11.44%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/  Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,187,465

11.44%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact Name:	Mirza Rahman
15. Contact telephone:	[phone]

Enquiries:

Proteome Sciences plc (01932 865 065) 
Christopher Pearce, CEO

James Malthouse, FD

Noble & Company Limited (020 7763 2200)
John Llewellyn-Lloyd

Sam Reynolds

 

END

 

 

HOLGUUMWMUPBGCQ